Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic
- 1 July 2020
- journal article
- letter
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (4), 577-578
- https://doi.org/10.1016/j.dsx.2020.05.010
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysisDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physiciansDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Clinical considerations for patients with diabetes in times of COVID-19 epidemicDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020